YARROW BIOSCIENCE, INC. Available-for-sale Securities, Gross Realized Gain (Loss)
YARROW BIOSCIENCE, INC. (YARW) reported Available-for-sale Securities, Gross Realized Gain (Loss) of $0 for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2019-10-31
- YARROW BIOSCIENCE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2019-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2019-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2019-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. available-for-sale securities, gross realized gain (loss) for the quarter ending 2018-09-30 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month |
|---|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 | $0.00 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |